Aug 21, 2025
Robotics Transforms Cell Therapy: Multiply Labs Drives Staggering 74% Cost Reduction, Unlocking Global Patient Access
Aug 13, 2025
Sapient Publishes Breakthrough rLC-MS Metabolomics Study in Over 26,000 Samples, Revealing Metabolic Aging Clock and Disease Insights
Aug 13, 2025
Avista Therapeutics and Forge Biologics Announce AAV Development and cGMP Manufacturing Partnership
Aug 12, 2025
Bruker Announces Quarterly Dividend
Jul 31, 2025
Charles River and BioTech Social Inc. Pursue Crowdfunding Partnership
Jul 16, 2025
Liquid Handling Systems Market Report 2025 with Focused Insights 2021-2030 and Exclusive Data on 39 Vendors - ResearchAndMarkets.com
Jul 15, 2025
Nu-Tek BioSciences to Showcase Animal-Free Industrial Fermentation Ingredients at SIMB 2025
Jun 26, 2025
AGC Biologics Expands Cell Therapy Development Operations to Asia to Serve Growing Market Need
Jun 24, 2025
MicroPure Genomics Awarded Competitive $1.25M SBIR Phase II Grant from the National Science Foundation
Jun 18, 2025
Objective Biotechnology Launches First-Ever Automated Microinjection Robot for Genetic Research
Jun 18, 2025
Cytiva and Argonaut Collaborate to Expand Reagent Lyophilization Manufacturing in EU and US
Jun 10, 2025
Nu-Tek BioSciences to Showcase Leadership in Animal-Free Cell Culture Solutions at BIO International Convention 2025
Jun 04, 2025
Integrated DNA Technologies Installs Custom Solutions Program to Accelerate Innovation in Synthetic Biology
May 28, 2025
Aphios Receives U.S. Patent Allowance for Groundbreaking Room Temperature-Stable, Single-Shot mRNA COVID-19 Vaccine
May 15, 2025
Argonaut Manufacturing Services Selected to Manufacture siRNA Medicines for Potential Prion Disease Trial
May 07, 2025
Univercells Technologies Debuts the scale-X™ Nitro Controller to Expand Access to Large-Scale Viral and Advanced Therapy Manufacturing
May 01, 2025
IDEX Reports First Quarter Results
Apr 30, 2025
InVitria Launches Optibumin® 25, the First Recombinant 25% Human Serum Albumin for Closed-System Biomanufacturing
Apr 29, 2025
QAD Joins California Life Sciences to Further Support Innovation and Growth in the Life Sciences Sector
Apr 24, 2025
U.S. FDA Approves Second Drug Product Manufacturing Facility for ADSTILADRIN® (nadofaragene firadenovec-vncg)